Europe Molecular Diagnostics Market Growth By Technology (Chips And Microarrays, PCR, In Situ Hybridization, Mass Spectrometry, Sequencing, Isothermal Amplification), By Application (Blood Screening, Infectious Disease, Genetic Testing, Oncology Testing), Regional Outlook (Germany, UK, France, Spain, Portugal, Italy, Russia, Denmark, Norway, Sweden), Industry Forecast, 2018 – 2024

Published Date: March 2019 | Publisher: Graphical Research Report ID: GR1142 | Delivery : PDF

Report Content

Chapter 1.Methodology

  1. Methodology
  2. Market definitions
  3. Forecast parameters
  4. Data sources
    1. Secondary
      1. Paid sources
      2. Unpaid sources
    2. Primary

Chapter 2.Executive Summary

  1. Europe molecular diagnostics industry 3600 synopsis, 2013 - 2024

Chapter 3.Europe Molecular Diagnostics Industry Insights

  1. Industry segmentation
  2. Industry landscape, 2013 - 2024
  3. Industry impact forces
    1. Growth drivers
      1. Increasing demand for personalized medicines in Europe
      2. Growing technological advancements
      3. Increasing geriatric population
      4. Escalating number of R&D activities
    2. Industry pitfalls and challenges
      1. High cost of diagnostic procedures
  4. Growth potential analysis
    1. By application
    2. By technology
  5. Regulatory landscape
    1. Europe
  6. Porter’s analysis
  7. Competitive landscape, 2017
    1. Strategy dashboard
  8. PESTEL analysis

Chapter 4.Europe Molecular Diagnostics Market, By Application

  1. Key segment trends
  2. Infectious diseases
    1. Market size, by country, 2013-2024 (USD Million)
    2. Flu
      1. Market size, by country, 2013-2024 (USD Million)
    3. RSV virus
      1. Market size, by country, 2013-2024 (USD Million)
    4. Tuberculosis
      1. Market size, by country, 2013-2024 (USD Million)
    5. Meningitis
      1. Market size, by country, 2013-2024 (USD Million)
    6. HIV market
      1. Market size, by country, 2013-2024 (USD Million)
    7. Hepatitis B
      1. Market size, by country, 2013-2024 (USD Million)
    8. Hepatitis C
      1. Market size, by country, 2013-2024 (USD Million)
    9. HPV
      1. Market size, by country, 2013-2024 (USD Million)
    10. STD
      1. Market size, by country, 2013-2024 (USD Million)
      2. Chlamydia
        1. Market size, by country, 2013-2024 (USD Million)
      3. Gonorrhea
        1. Market size, by country, 2013-2024 (USD Million)
      4. Others
        1. Market size, by country, 2013-2024 (USD Million)
    11. Dengue
      1. Market size, by country, 2013-2024 (USD Million)
  3. H. pylori
    1. Market size, by country, 2013-2024 (USD Million)
  4. TORCH
    1. Market size, by country, 2013-2024 (USD Million)
  5. Others
    1. Market size, by country, 2013-2024 (USD Million)
  6. Blood screening
    1. Market size, by country, 2013-2024 (USD Million)
  7. Genetic testing
    1. Market size, by country, 2013-2024 (USD Million)
  8. Oncology testing
    1. Market size, by country, 2013-2024 (USD Million)

Chapter 5.Europe Molecular Diagnostics Market, By Technology

  1. Key segment trends
  2. PCR
    1. Market size, by country, 2013-2024 (USD Million)
  3. In-situ hybridization
    1. Market size, by country, 2013-2024 (USD Million)
  4. Chips & microarrays
    1. Market size, by country, 2013-2024 (USD Million)
  5. Mass spectroscopy
    1. Market size, by country, 2013-2024 (USD Million)
  6. Sequencing
    1. Market size, by country, 2013-2024 (USD Million)
  7. Isothermal amplification
    1. Market size, by country, 2013-2024 (USD Million)
  8. Others
    1. Market size, by country, 2013-2024 (USD Million)

Chapter 6.Europe Molecular Diagnostics Market, By Country

  1. Key country trend
  2. Europe
    1. Market size, by country, 2013 - 2024(USD Million)
    2. Market size, by application, 2013 - 2024(USD Million)
    3. Market size, by technology, 2013 - 2024(USD Million)
    4. Germany
      1. Market size, by application, 2013 - 2024(USD Million)
      2. Market size, by technology, 2013 - 2024(USD Million)
    5. UK
      1. Market size, by application, 2013 - 2024(USD Million)
      2. Market size, by technology, 2013 - 2024(USD Million)
    6. France
      1. Market size, by application, 2013 - 2024(USD Million)
      2. Market size, by technology, 2013 - 2024(USD Million)
    7. Italy
      1. Market size, by application, 2013 - 2024(USD Million)
      2. Market size, by technology, 2013 - 2024(USD Million)
    8. Spain
      1. Market size, by application, 2013 - 2024(USD Million)
      2. Market size, by technology, 2013 - 2024(USD Million)
    9. Portugal
      1. Market size, by application, 2013 - 2024(USD Million)
      2. Market size, by technology, 2013 - 2024(USD Million)
    10. Denmark
      1. Market size, by application, 2013 - 2024(USD Million)
      2. Market size, by technology, 2013 - 2024(USD Million)
    11. Norway
      1. Market size, by application, 2013 - 2024(USD Million)
      2. Market size, by technology, 2013 - 2024(USD Million)
    12. Sweden
      1. Market size, by application, 2013 - 2024(USD Million)
      2. Market size, by technology, 2013 - 2024(USD Million)
    13. Russia
      1. Market size, by application, 2013 - 2024(USD Million)
      2. Market size, by technology, 2013 - 2024(USD Million)
    14. Others
      1. Market size, by application, 2013 - 2024(USD Million)
      2. Market size, by technology, 2013 - 2024(USD Million)

 

Chapter 7.Company Profiles

  1. Abbott Molecular
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  2. Agilent (Dako)
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  3. Alere Inc.
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  4. Analytik Jena AG
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  5. Becton Dickinson
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  6. Biocartis Group
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  7. BioFire Diagnostics
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  8. Biomerieux
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  9. Bio-Rad Laboratories
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  10. Bio-Techne
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  11. Cephied
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  12. Cleaver Scientific
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  13. CombiMatrix
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  14. Danaher Corporation
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  15. GenMark Diagnostics
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  16. Genomic Health, Inc.
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  17. Hologic (Gen Probe)
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  18. HTG Molecular Diagnostics
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  19. MDx Health
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  20. Myriad Genetics
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  21. Novartis
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  22. Qiagen
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  23. Roche Diagnostics
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  24. Rosetta Genomics
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  25. SCILOGEX, LLC
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  26. Siemens Healthcare
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis
  27. Sysmex
    1. Business overview
    2. Financial data
    3. Product landscape
    4. Strategic outlook
    5. SWOT analysis

 

Data Tables

TABLE 1.Molecular diagnostics industry 3600 synopsis, 2013 – 2024

TABLE 2.Industry impact forces

TABLE 3.Molecular diagnostics market, pipeline analysis

TABLE 4.Infectious disease market size, by country, 2013 – 2024 (USD Million)

TABLE 5.Flu market size, by country, 2013 – 2024 (USD Million)

TABLE 6.RSV virus market size, by country, 2013 – 2024 (USD Million)

TABLE 7.Tuberculosis market size, by country, 2013 – 2024 (USD Million)

TABLE 8.Meningitis market size, by country, 2013 – 2024 (USD Million)

TABLE 9.HIV market size, by country, 2013 – 2024 (USD Million)

TABLE 10.Hepatitis C market size, by country, 2013 – 2024 (USD Million)

TABLE 11.Hepatitis B market size, by country, 2013 – 2024 (USD Million)

TABLE 12.HPV market size, by country, 2013 – 2024 (USD Million)

TABLE 13.STD market size, by country, 2013 – 2024 (USD Million)

TABLE 14.Chlamydia market size, by country, 2013 – 2024 (USD Million)

TABLE 15.Gonorrhea market size, by country, 2013 – 2024 (USD Million)

TABLE 16.Others market size, by country, 2013 – 2024 (USD Million)

TABLE 17.Dengue market size, by country, 2013 – 2024 (USD Million)

TABLE 18.H. Pylori market size, by country, 2013 – 2024 (USD Million)

TABLE 19.TORCH market size, by country, 2013 – 2024 (USD Million)

TABLE 20.Others market size, by country, 2013 – 2024 (USD Million)

TABLE 21.Blood screening market size, by country, 2013 – 2024 (USD Million)

TABLE 22.Genetic testing market size, by country, 2013 – 2024 (USD Million)

TABLE 23.Oncology testing market size, by country, 2013 – 2024 (USD Million)

TABLE 24.PCR testing market size, by country, 2013 – 2024 (USD Million)

TABLE 25.In Situ Hybridization market size, by country, 2013 – 2024 (USD Million)

TABLE 26.Chips and microarrays testing market size, by country, 2013 – 2024 (USD Million)

TABLE 27.Mass spectrometry testing market size, by country, 2013 – 2024 (USD Million)

TABLE 28.Sequencing testing market size, by country, 2013 – 2024 (USD Million)

TABLE 29.Isothermal amplification testing market size, by country, 2013 – 2024 (USD Million)

TABLE 30.Others market size, by country, 2013 – 2024 (USD Million)

TABLE 31.Europe molecular diagnostics market size, by country, 2013 - 2024 (USD Million)

TABLE 32.Europe molecular diagnostics market size, by application, 2013 - 2024 (USD Million)

TABLE 33.Europe molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)

TABLE 34.Europe molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)

TABLE 35.Europe molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)

TABLE 36.Germany molecular diagnostics market size, by application, 2013 - 2024 (USD Million)

TABLE 37.Germany molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)

TABLE 38.Germany molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)

TABLE 39.Germany molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)

TABLE 40.UK molecular diagnostics market size, by application, 2013 - 2024 (USD Million)

TABLE 41.UK molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)

TABLE 42.UK molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)

TABLE 43.UK molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)

TABLE 44.France molecular diagnostics market size, by application, 2013 - 2024 (USD Million)

TABLE 45.France molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)

TABLE 46.France molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)

TABLE 47.France molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)

TABLE 48.Italy molecular diagnostics market size, by application, 2013 - 2024 (USD Million)

TABLE 49.Italy molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)

TABLE 50.Italy molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)

TABLE 51.Italy molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)

TABLE 52.Spain molecular diagnostics market size, by application, 2013 - 2024 (USD Million)

TABLE 53.Spain molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)

TABLE 54.Spain molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)

TABLE 55.Spain molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)

TABLE 56.Portugal molecular diagnostics market size, by application, 2013 - 2024 (USD Million)

TABLE 57.Portugal molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)

TABLE 58.Portugal molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)

TABLE 59.Portugal molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)

TABLE 60.Denmark molecular diagnostics market size, by application, 2013 - 2024 (USD Million)

TABLE 61.Denmark molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)

TABLE 62.Denmark molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)

TABLE 63.Denmark molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)

TABLE 64.Norway molecular diagnostics market size, by application, 2013 - 2024 (USD Million)

TABLE 65.Norway molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)

TABLE 66.Norway molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)

TABLE 67.Norway molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)

TABLE 68.Sweden molecular diagnostics market size, by application, 2013 - 2024 (USD Million)

TABLE 69.Sweden molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)

TABLE 70.Sweden molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)

TABLE 71.Sweden molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)

TABLE 72.Russia molecular diagnostics market size, by application, 2013 - 2024 (USD Million)

TABLE 73.Russia molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million)

TABLE 74.Russia molecular diagnostics market size, by STDs, 2013 - 2024 (USD Million)

TABLE 75.Russia molecular diagnostics market size, by technology, 2013 - 2024 (USD Million)

Charts & Figures

FIG 1. Industry segmentation

FIG 2.Europe molecular diagnostics market, 2013 – 2024 (USD Million)

FIG 3.Growth potential analysis, by application

FIG 4.Growth potential analysis, by technology

FIG 5.Comparative study between conventional culture method and molecular testing method

FIG 6.Porter’s analysis

FIG 7.Strategy dashboard

FIG 8.PESTEL analysis

Select License

Europe Molecular Diagnostics Market Statistics Analysis Report 2024


Related Reports
Why Choose us?